Search

everythinglearnresearchcommunity

for

Search:↓

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Upadacitinib may cause hair loss.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Astragaloside A may help fight lung cancer by targeting specific proteins.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Dutasteride is a safe and effective treatment for hair loss.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.